SARTORIUS (OTCMKTS:SARTF) AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies. Its product range includes single-use bioreactors, tangential flow filtration systems, media and buffer preparation tools and process analytics. In the Lab Products & Services segment, Sartorius offers high-precision laboratory balances, pipetting devices, lab filtration products and software-driven services aimed at improving workflow efficiency and data integrity in quality control and R&D laboratories.
Founded in 1870 in Göttingen, Germany, Sartorius has expanded its global footprint with production and service sites across Europe, North America and Asia. The company supports research institutions, contract development and manufacturing organizations (CDMOs) and major pharmaceutical manufacturers in over 100 countries. Its executive board is chaired by Dr. Joachim Kreuzburg, under whose leadership Sartorius has pursued both organic growth and strategic acquisitions to strengthen its technology portfolio and international presence.
